These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 11284463)
21. Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks. Müller T; Lohse L Clin Neuropharmacol; 2011; 34(6):206-9. PubMed ID: 21996647 [TBL] [Abstract][Full Text] [Related]
22. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016 [TBL] [Abstract][Full Text] [Related]
23. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group. Teall J; Tuchman M; Cutler N; Gross M; Willoughby E; Smith B; Jiang K; Reines S; Block G Headache; 1998 Apr; 38(4):281-7. PubMed ID: 9595867 [TBL] [Abstract][Full Text] [Related]
24. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142 [TBL] [Abstract][Full Text] [Related]
25. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569 [TBL] [Abstract][Full Text] [Related]
26. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Ashcroft DM; Millson D Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068 [TBL] [Abstract][Full Text] [Related]
27. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study. Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500 [TBL] [Abstract][Full Text] [Related]
28. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group. Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025 [TBL] [Abstract][Full Text] [Related]
29. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M; Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714 [TBL] [Abstract][Full Text] [Related]
30. Treatment of migraine with rizatriptan: when to take the medication. Hu XH; Raskin NH; Cowan R; Markson LE; Berger ML; Headache; 2002 Jan; 42(1):16-20. PubMed ID: 12005270 [TBL] [Abstract][Full Text] [Related]
31. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons. Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077 [TBL] [Abstract][Full Text] [Related]
33. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898 [TBL] [Abstract][Full Text] [Related]
34. Sumatriptan (intranasal route of administration) for acute migraine attacks in adults. Derry CJ; Derry S; Moore RA Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009663. PubMed ID: 22336867 [TBL] [Abstract][Full Text] [Related]
35. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. Solomon S; Frishberg B; Hu XH; Markson L; Berger M Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288 [TBL] [Abstract][Full Text] [Related]
36. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Tfelt-Hansen P; De Vries P; Saxena PR Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011 [TBL] [Abstract][Full Text] [Related]
37. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R; Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432 [TBL] [Abstract][Full Text] [Related]
39. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Gallagher RM; Dennish G; Spierings EL; Chitra R Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911 [TBL] [Abstract][Full Text] [Related]
40. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]